Suchergebnisse - "Jakate, Abhijeet"

PubPharm (34)

1

Pharmacokinetics, safety, and tolerability of fosmanogepix IV to oral switch and multiple IV doses in healthy participants

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Hodges, M. | Hazel, S. | Kramer, W. | +4

2

Safety and Pharmacokinetics of Intravenous and Oral Fosmanogepix, a First-in-Class Antifungal Agent, in Healthy Volunteers

enthalten in: Antimicrobial agents and chemotherapy | 2023

von Hodges, M. | Ople, E. | Wedel, P. | +6

3

Atogepant and sumatriptan : no clinically relevant drug-drug interactions in a randomized, open-label, crossover trial

enthalten in: Pain management | 2022

von Boinpally, R. | Jakate, A. | Butler, M. | +1

4

Single-Dose Pharmacokinetics and Safety of Atogepant in Adults With Hepatic Impairment : Results From an Open-Label, Phase 1 Trial

enthalten in: Clinical pharmacology in drug development | 2021

von Boinpally, R. | Jakate, A. | Butler, M. | +2

5

Time course of efficacy of ubrogepant for the acute treatment of migraine : Clinical implications

enthalten in: Cephalalgia : an international journal of headache | 2021

von Goadsby, P. | Blumenfeld, A. | Lipton, R. | +7

6

Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene-related peptide-targeted monoclonal antibody migraine preventives in participants with migraine : A randomized phase 1b drug-drug interaction study

enthalten in: Headache | 2021

von Jakate, A. | Blumenfeld, A. | Boinpally, R. | +6

7

Similar pharmacokinetics of three dosing regimens comprising two oral delayed-release mesalamine formulations in healthy adult volunteers : Randomised, open-label, parallel-group study

enthalten in: British journal of clinical pharmacology | 2021

von Vande Casteele, N. | Jakate, A. | McNamee, B. | +1

8

Single‐Dose Pharmacokinetics and Safety of Atogepant in Adults With Hepatic Impairment : Results From an Open‐Label, Phase 1 Trial

enthalten in: Clinical Pharmacology in Drug Development | 2021

von Boinpally, R. | Jakate, A. | Butler, M. | +2

9

Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene‒related peptide‐targeted monoclonal antibody migraine preventives in participants with migraine : A randomized phase 1b drug–drug interaction study

enthalten in: Headache: The Journal of Head and Face Pain | 2021

von Jakate, A. | Blumenfeld, A. | Boinpally, R. | +6

10

Evaluation of the Pharmacokinetic Interaction of Ubrogepant Coadministered With Sumatriptan and of the Safety of Ubrogepant With Triptans

enthalten in: Headache | 2020

von Jakate, A. | Boinpally, R. | Butler, M. | +3